logo

Astellas Pharma Inc. (ALPMY)



Trade ALPMY now with
  Date
  Headline
2/11/2020 8:04:35 AM Astellas Pharma And Pfizer Announce Results Of Final Overall Survival Analysis From Phase 3 PROSPER Trial
1/30/2020 12:10:03 AM Astellas Submits SNDA For Approval Of Evrenzo For Anemia Associated With CKD In Non-Dialysis Dependent Patients In Japan
1/15/2020 8:24:24 AM Astellas Pharma Completes Acquisition Of Audentes Therapeutics
1/14/2020 2:30:03 AM Astellas, Adaptimmune Enter Co-development And Co-commercialization Agreement
12/2/2019 8:11:35 PM Astellas Presents New Data On XOSPATA In FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia
12/2/2019 8:05:08 AM Seattle Genetics, Astellas Pharma Announce Clinical Collaboration Agreement With Merck
11/20/2019 8:08:06 PM Astellas, Welldoc Enter Into Strategic Alliance For Digital Therapeutics
10/28/2019 9:03:01 AM FDA Grants Fast Track Designation To Astellas For Development Of ASP1128 For Patients At Risk For Acute Kidney Injury
10/25/2019 3:04:12 AM EC Approves Astellas' XOSPATA As Monotherapy For Patients With Relapsed Or Refractory AML With FLT3 Mutation
  
 
>